Bioscience News - GEG Tech top picks

A 36-year-old man in Brazil has seemingly cleared an HIV infection—making him the proof of principle in humans of a novel drug strategy designed to flush the AIDS virus out of all of its reservoirs in the body. After receiving an especially aggressive combination of antiretroviral (ARV) drugs and nicotinamide (vitamin B3), the man, who asks to be referred to as the São Paulo Patient to protect his privacy, went off all HIV treatment in March 2019 and has not had the virus return to his blood.

For World AIDS Day, a French institute, the IIDSRSI, announced the launch of an anti-HIV medication on the African market. However, the medication in question has not been proven to be effective. The institute is supported by renowned scientists such as Professors Jean Claude Chermann (France) and Mark Wainberg (Canada). This article exposes the underbelly of this trafficking.

The International AIDS Society president has called on the United States to "stay engaged" in HIV research. US President Donald Trump's proposed budget outlined funding cuts for global health initiatives.